Lingling Lei

611 total citations · 1 hit paper
20 papers, 469 citations indexed

About

Lingling Lei is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Lingling Lei has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 8 papers in Molecular Biology and 7 papers in Materials Chemistry. Recurrent topics in Lingling Lei's work include Nanoplatforms for cancer theranostics (10 papers), Advanced Nanomaterials in Catalysis (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Lingling Lei is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Advanced Nanomaterials in Catalysis (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Lingling Lei collaborates with scholars based in China, South Korea and United States. Lingling Lei's co-authors include Guosheng Song, Xiaobing Zhang, Renye Yue, Youjuan Wang, Guoqiang Guan, Zhe Dong, Li Xu, Fengrui Yang, Guoqiang Guan and Cheng Zhang and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Lingling Lei

17 papers receiving 464 citations

Hit Papers

Chemical Design of Magnetic Nanomaterials for Imaging and... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingling Lei China 10 290 188 134 108 100 20 469
S. Sibel Erdem United States 12 284 1.0× 182 1.0× 163 1.2× 239 2.2× 90 0.9× 20 608
Linan Shi China 8 366 1.3× 265 1.4× 211 1.6× 66 0.6× 94 0.9× 10 601
Huocheng Yang China 7 521 1.8× 241 1.3× 149 1.1× 133 1.2× 116 1.2× 12 670
Sandhya Clement Australia 13 482 1.7× 209 1.1× 126 0.9× 274 2.5× 186 1.9× 22 698
Shuyue Ye China 14 566 2.0× 336 1.8× 226 1.7× 147 1.4× 116 1.2× 19 719
Yinxing Miao China 14 356 1.2× 196 1.0× 189 1.4× 65 0.6× 103 1.0× 31 563
Jianshuang Wei China 10 311 1.1× 133 0.7× 68 0.5× 56 0.5× 73 0.7× 41 406
Martyna Krzykawska-Serda Poland 12 254 0.9× 161 0.9× 92 0.7× 151 1.4× 47 0.5× 30 512
Mingxi Zhang China 12 380 1.3× 268 1.4× 119 0.9× 44 0.4× 86 0.9× 32 526
Sonia Kumar United States 9 255 0.9× 121 0.6× 265 2.0× 70 0.6× 122 1.2× 17 606

Countries citing papers authored by Lingling Lei

Since Specialization
Citations

This map shows the geographic impact of Lingling Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Lei more than expected).

Fields of papers citing papers by Lingling Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Lei. The network helps show where Lingling Lei may publish in the future.

Co-authorship network of co-authors of Lingling Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Lei. A scholar is included among the top collaborators of Lingling Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Lei. Lingling Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Lingling, et al.. (2025). Ultrasound-responsive engineered bacteria mediated specific controlled expression of catalase and efficient radiotherapy. Materials Today Bio. 31. 101620–101620. 3 indexed citations
2.
Zhang, Yu, Yanni Wang, Lingling Lei, et al.. (2025). Design and synthesis of stilbene analogs based on resveratrol as NF-κB inhibitors for the treatment of breast cancer. Molecular Diversity. 30(1). 897–911.
3.
Lei, Lingling, et al.. (2025). Dual-pathway tumor radiosensitization strategy based on engineered bacteria capable of targeted delivery of AuNPs and specific hypoxia alleviation. Journal of Nanobiotechnology. 23(1). 254–254. 5 indexed citations
4.
Xu, Wei, Guoqiang Guan, Renye Yue, et al.. (2025). Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy. Chemical Reviews. 125(4). 1897–1961. 25 indexed citations breakdown →
5.
Lei, Lingling, Qing Zhang, Meng Du, & Li Li. (2025). Mechanoregulation of Cell Fate by Low-intensity Pulsed Ultrasound: Mechanisms and Advances in Regenerative Medicine. Charles Sturt University Research Output (CRO). 6(1).
6.
Yang, Fengrui, Xing Jiang, Lingling Lei, et al.. (2025). Tumor Microenvironment-Responsive Lipid Nanoparticle for Blocking Mitosis and Reducing Drug Resistance in NSCLC. Journal of Medicinal Chemistry. 68(3). 3814–3823.
7.
Lei, Lingling, et al.. (2024). The potential of vascular normalization for sensitization to radiotherapy. Heliyon. 10(12). e32598–e32598. 4 indexed citations
8.
Lei, Lingling, Zhe Dong, Fengrui Yang, & Xiaobing Zhang. (2024). Metal–Organic Nanomaterials for Tumor Metabolic Blockade and Image to Increase Tumor Therapy. ACS Applied Materials & Interfaces. 16(43). 57995–58005. 4 indexed citations
9.
Guan, Guoqiang, Huiyi Liu, Qingpeng Zhang, et al.. (2024). Responsive Magnetic Particle Imaging Tracer: Overcoming “Always‐On” Limitation, Eliminating Interference, and Ensuring Safety in Adaptive Therapy. Advanced Materials. 36(49). e2409117–e2409117. 4 indexed citations
10.
Xu, Juntao, Guoqiang Guan, Cheng Zhang, et al.. (2023). Enhancing lipid peroxidation via radical chain transfer reaction for MRI guided and effective cancer therapy in mice. Science Bulletin. 69(5). 636–647. 15 indexed citations
11.
Guan, Guoqiang, Huiyi Liu, Qingpeng Zhang, et al.. (2023). Ultrasmall PtMn nanoparticles as sensitive manganese release modulator for specificity cancer theranostics. Journal of Nanobiotechnology. 21(1). 434–434. 7 indexed citations
12.
Yang, Fengrui, et al.. (2023). Engineering Cell-Selective Charge-Altering Lipid Nanoparticles for Efficient siRNA Delivery in Vivo. CCS Chemistry. 6(8). 2054–2065. 8 indexed citations
13.
Xu, Li, Chang Lu, Huiyi Liu, et al.. (2023). Dynamic–Reversible MRI Nanoprobe for Continuous Imaging Redox Homeostasis in Hepatic Ischemia–Reperfusion Injury. ACS Nano. 17(10). 9529–9542. 42 indexed citations
14.
Lei, Lingling, Fengrui Yang, Xin Meng, et al.. (2023). Noninvasive Imaging of Tumor Glycolysis and Chemotherapeutic Resistance via De Novo Design of Molecular Afterglow Scaffold. Journal of the American Chemical Society. 145(44). 24386–24400. 58 indexed citations
16.
Yue, Renye, Ziqi Zhou, Xu Li, et al.. (2023). GSH/APE1 Cascade-Activated Nanoplatform for Imaging Therapy Resistance Dynamics and Enzyme-Mediated Adaptive Ferroptosis. ACS Nano. 17(14). 13792–13810. 43 indexed citations
17.
Li, Zhe, Li Xu, Jinyu Li, et al.. (2023). Superoxide Anion-Mediated Afterglow Mechanism-Based Water-Soluble Zwitterion Dye Achieving Renal-Failure Mice Detection. Journal of the American Chemical Society. 145(49). 26736–26746. 40 indexed citations
18.
Lei, Lingling, Fengrui Yang, Li Xu, et al.. (2023). Zinc–Carnosine Metallodrug Network as Dual Metabolism Inhibitor Overcoming Metabolic Reprogramming for Efficient Cancer Therapy. Nano Letters. 23(7). 2659–2668. 43 indexed citations
19.
Lei, Lingling, Zhe Dong, Xu Li, et al.. (2022). Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation. Theranostics. 12(14). 6207–6222. 41 indexed citations
20.
Yue, Renye, Cheng Zhang, Li Xu, et al.. (2022). Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy. Chem. 8(7). 1956–1981. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026